MARY MARTIN: Open Payments
NPI 1790910891 · SPRINGVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 79 payments from 22 companies in 2025. Trend: 2023 $1,602 · 2024 $1,336 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $175 |
| GlaxoSmithKline, LLC. | 11 | $175 |
| Novo Nordisk Inc | 9 | $161 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Almatica Pharma LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Exact Sciences Corporation | 3 | $53 |
| Dexcom, Inc. | 2 | $46 |
Products named: REXULTI, Kerendia, TRELEGY ELLIPTA, CAPLYTA, Ozempic, LOREEV XR, Auvelity, BREZTRI.
Industry payments across AL — which companies pay providers there.
